Featured Guests
Paul Armentano

Paul Armentano is deputy director of NORML, and the National Organization for the Reform of Marijuana Laws, and a...

Ben Cort

Ben Cort is business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), part of the University...

Your Host
J. Craig Williams

J. Craig Williams is admitted to practice law in Iowa, California, Massachusetts, and Washington. Before attending law school, his...

In a recent decision, the Drug Enforcement Administration ruled that marijuana will remain a Schedule 1 substance under the Controlled Substances Act. Substances in Schedule 1 are determined by the Food and Drug Administration to be drugs with no currently accepted medical use and a high potential for abuse.  

On Lawyer 2 Lawyer, host J. Craig Williams joins Paul Armentano, deputy director of NORML and Ben Cort, business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), to discuss the recent decision by the DEA to keep marijuana on the Schedule 1 list. They will talk impact, the legalization of marijuana, manufacturing marijuana for scientific purposes, and what the future holds on this controversial topic.

Paul Armentano is deputy director of NORML, and the National Organization for the Reform of Marijuana Laws, and a senior policy advisor at Freedom Leaf, Inc: The Marijuana Legalization Company. He is the co-author of the book “Marijuana is Safer: So Why Are We Driving People to Drink?” Paul was also the principal investigator for defense counsel in U.S. v Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule I controlled substance.

Ben Cort is business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), part of the University of Colorado Health system. Ben’s passion for recovery, prevention and harm reduction comes from his own struggle with substance abuse. Sober since 1996, Cort is also a junior fellow at the University of Florida’s Drug Policy Institute and serves on the boards of Project SAM (Smart Approaches to Marijuana) and the Stout Street Foundation.

Special thanks to our sponsor, Clio.


Full Transcript

 View Transcript

Brought to You by
Episode Details
Published: September 30, 2016
Podcast: Lawyer 2 Lawyer
Category: Legal News , Medical Law
This Podcast
Lawyer 2 Lawyer
Lawyer 2 Lawyer

Lawyer 2 Lawyer is a legal affairs podcast covering contemporary and relevant issues in the news with a legal perspective.

  iTunes   Google Play
More Episodes
05/26/17
Inside the FBI, Comey Firing, and the Russia Connection

This legal podcast covers the dismissal of FBI Director James Comey, the legalities triggered by dismissals, and the Russia connection.

05/12/17
Assessment Drives Learning: The Solicitors Qualifying Exam Eliminates U.K. Law School Requirement

This legal podcast discusses how the U.K. is eliminating the requirement of attending law school in favor of a skills exam and whether or...

04/28/17
The Aftermath of the Massachusetts Drug Lab Scandal and the Dismissal of 21,000 Cases

This podcast looks at the drug lab scandal in Mass. and its impact on drug cases, attorneys, defendants, and takes a look at what...

04/14/17
Your Browser History: How Recent ISP Legislation Affects Privacy

In this podcast they talk about Trump's new legislation that allows internet providers or ISPs to sell customer data without consent.

03/31/17
Will Budget Cuts to the Legal Services Corporation Diminish Access To Justice?

Jim Sandman and Linda Klein discuss President Trump’s budget proposal to zero out funding for the Legal Services Corporation.

03/17/17
President Trump vs. the Press

The First Amendment, Trump/press relationship, what constitutes “fake news,” the freedom of the press, and potential future litigation involving the press.